Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases

Irbesartan attenuates ischemic brain damage by inhibition of MCP-1/CCR2 signaling pathway beyond AT1 receptor blockade

(2011) Kana Tsukuda et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats

(2011) Koji Yamada et al.   BRAIN RESEARCH

Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease

(2011) Yi-Fei Dong et al.   FASEB JOURNAL

Effect of Angiotensin II Type 2 Receptor Deletion in Hematopoietic Cells on Brain Ischemia-Reperfusion Injury

(2011) Jun Iwanami et al.   HYPERTENSION

Angiotensin II induces human astrocyte senescence through reactive oxygen species production

(2011) Gang Liu et al.   HYPERTENSION RESEARCH

Direct Stimulation of Angiotensin II Type 2 Receptor Enhances Spatial Memory

(2011) Fei Jing et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia

(2010) Costantino Iadecola   ACTA NEUROPATHOLOGICA

Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease

(2010) Koji Yamada et al.   BRAIN RESEARCH

Angiotensin II sustains brain inflammation in mice via TGF-β

(2010) Tobias V. Lanz et al.   JOURNAL OF CLINICAL INVESTIGATION

Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study

(2009) T. Sawada et al.   EUROPEAN HEART JOURNAL

Remote control of brain angiotensin II levels by angiotensin receptor blockers

(2009) Masaki Mogi et al.   HYPERTENSION RESEARCH

Systemic candesartan reduces brain angiotensin II via downregulation of brain renin–angiotensin system

(2009) Nicolas Pelisch et al.   HYPERTENSION RESEARCH

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme

(2009) Kun Zou et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic

(2009) Zheng Gang Zhang et al.   LANCET NEUROLOGY

Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis

(2009) M Kawajiri et al.   Multiple Sclerosis Journal

Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system

(2009) J. Stegbauer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis

(2008) M. Kawajiri et al.   ACTA NEUROLOGICA SCANDINAVICA

Attenuation of Focal Brain Ischemia by Telmisartan, an Angiotensin II Type 1 Receptor Blocker, in Atherosclerotic Apolipoprotein E-Deficient Mice

(2008) Masaru IWAI et al.   HYPERTENSION RESEARCH

Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis

(2008) M Kawajiri et al.   Multiple Sclerosis Journal

Deletion of Angiotensin II Type 2 Receptor Attenuates Protective Effects of Bone Marrow Stromal Cell Treatment on Ischemia–Reperfusion Brain Injury in Mice

(2008) Jun Iwanami et al.   STROKE

Temporary Pretreatment With the Angiotensin II Type 1 Receptor Blocker, Valsartan, Prevents Ischemic Brain Damage Through an Increase in Capillary Density

(2008) Jian-Mei Li et al.   STROKE

Exaggeration of Focal Cerebral Ischemia in Transgenic Mice Carrying Human Renin and Human Angiotensinogen Genes

(2008) Shinji Inaba et al.   STROKE